Patent · US Active

Selective HDAC3 inhibitors

US9096549B2 · kind B2 · utility

23Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2014
Grant dateAug 4, 2015
Priority date—
Expiry dateJan 31, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D241/44
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are HDAC3 inhibitors, as well as methods of treatment comprising administering these compounds to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.